Most Down Articles

    Published in last 1 year| In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

    Published in last 1 year
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Clinical and CT features of non-small cell lung cancer SMARCA4 expression deficiency
    ZHANG Xuekun, CHEN Xiaoyan, XIA Xinyun, CHENG Zenghui
    Journal of Internal Medicine Concepts & Practice    2025, 20 (04): 282-288.   DOI: 10.16138/j.1673-6087.2025.04.04
    Abstract173)   HTML13)    PDF(pc) (2743KB)(694)       Save

    Objective To explore the clinical and CT features of SMARCA4-deficient non-small cell lung cancer (SMARCA4-dNSCLC ). Methods SMARCA4-dNSCLC cases confirmed histopathologically were enrolled and analyzed retrospectively in our hospital from January 2018 to January 2022. Using SMARCA4-intact NSCLC (SMARCA4-iNSCLC) cases admitted during the same period as control, the clinical characteristics and CT features of SMARCA4-dNSCLC cases were observed, recorded and compared. Results There were 42 cases in the SMARCA4-dNSCLC group and 43 cases in SMARCA4-iNSCLC control group, respectively. Compared with the control, the SMARCA4-dNSCLC group had a higher proportion of males, smokers, and chronic obstructive pulmonary disease (COPD). Clinically, the SMARCA4-dNSCLC group exhibited a higher incidence of superior vena cava syndrome, while the SMARCA4-iNSCLC group presented with hemoptysis more frequently. On CT imaging, tumors in the SMARCA4-dNSCLC group showed relatively homogeneous density, fewer cystic changes, necrosis, or calcification, more ill-defined borders, and a lower rate of associated obstructive pneumonia/atelectasis. Conclusions SMARCA4-dNSCLC was more frequently seen in elderly males and heavy smokers and was frequently accompanied by COPD. Occasionally, it could present with superior vena cava syndrome. The tumors were prone to locate in the upper lobes of both lungs. On CT imaging, it mostly presented as a soft tissue mass with relatively homogenous density, ill-defined boundaries, without cystic changes or cavities, and calcification was rare. The vast majority showed significant heterogenous enhancement after contrast. Mediastinal lymph node metastasis was common. This unique subtype of NSCLC should be considered in patients with the above clinical and CT features.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Treatment strategies for renal impairment in multiple myeloma: a review of new drugs and novel therapies
    SHI Hao, WANG Zhaohui
    Journal of Internal Medicine Concepts & Practice    2025, 20 (03): 185-190.   DOI: 10.16138/j.1673-6087.2025.03.01
    Abstract276)   HTML20)    PDF(pc) (892KB)(452)       Save

    Multiple myeloma (MM) is associated with a high incidence of renal impairment, which correlates with decreased overall survival and increased risk of early mortality in these patients. In recent years, there has been great progress in the treatment of MM, and new drugs and therapies have improved prognosis of the patients. However, the prognosis of MM patients with concurrent renal impairment remains poorer compared with those with normal renal function. This article reviews the advancements in treatment and relevant strategies for MM patients with renal impairment. Current research supports the regime of combining monoclonal antibodies with proteasome inhibitors or immunomodulatory drugs in MM treatment. Chimeric antigen receptor T cells therapy, T-cell directing bispecific antibodies and antibody-drug conjugates have only been evaluated in small-scale retrospective studies for patients with renal impairment. Although the benefits of mechanical approaches aiming at rapid clearance of free light chains, such as plasmapheresis and high-cutoff hemodialysis, have not been confirmed, they may provide opportunities for renal recovery as combing with chemotherapy. The efficacy and safety of treatment in MM patients with renal impairment should be proactively assessed in prospective randomized controlled trials.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Advances in age-associated B cell in systemic lupus erythematosus
    FAN Yuxin, BIN Zexuan, ZHANG Xin, LUO Jing, WANG Caihong
    Journal of Internal Medicine Concepts & Practice    2025, 20 (04): 328-333.   DOI: 10.16138/j.1673-6087.2025.04.13
    Abstract191)   HTML5)    PDF(pc) (969KB)(442)       Save

    Age associated B cell (ABC) is a new type of effector B cell subset, which is characterized by continuous expansion with age. However, it is abnormally expressed prematurely in patients with certain autoimmune diseases and/or infectious diseases. ABC highly expresses CD11c and transcription factor T-bet in mice and human, and lowly expresses CD21. ABC is considered a memory B cell subtype driven by autoantigen and has the potential to differentiate into plasmablasts and produce autoantibodies. In systemic lupus erythematosus (SLE), ABC is abnormally amplified and correlated with disease activity and organ involvement. An important mechanism to promote the production of autoantibodies and accelerate disease progression is the single gene mutation inducing the proliferation and differentiation of ABC into extrafollicular effector B cell. Recent studies have revealed that zinc finger E-box binding homeobox 2 (ZEB2) is a key transcription factor for the specialization of the ABC cell lineage, and the ZEB2-Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway play a core role in their differentiation. Further study on the role of ABC in the pathogenesis of SLE will help to provide new targets for clinical treatment.

    Reference | Related Articles | Metrics | Comments0
    Interaction between bile acids and gut microbiota and their role in Parkinson disease
    LIU Shumeng, AI Penghui, XIAO Qin, YANG Xiaodong
    Journal of Internal Medicine Concepts & Practice    2025, 20 (04): 345-350.   DOI: 10.16138/j.1673-6087.2025.04.16
    Abstract118)   HTML6)    PDF(pc) (1002KB)(433)       Save

    Bile acids are amphipathic molecules derived from cholesterol, which facilitate the absorption of lipids, and also serve as signaling molecules in regulating metabolic homeostasis and immune response. Bile acid is modified by intestinal flora, and on the other hand, it alters the composition of gut microbiota and exerts potential effects on the microbiota-gut-brain axis(MGBA). Through this bidirectional communication system, bile acid signaling homeostasis plays a modulatory role for maintaining the physiological function of nervous system. In recent years, increasing evidence indicates that the bile acid associated with dysbiosis in gut microbiota may be an early sign of Parkinson disease (PD), which triggered the exploration of new pathological mechanisms and diagnostic biomarkers for PD. This article reviews the relationship between abnormal bile acid metabolism and PD as well as its potential role in PD treatment from the perspective of interaction between bile acids and intestinal microorganism.

    Reference | Related Articles | Metrics | Comments0
    Heavy and light chain renal amyloidosis with biclonal paraproteinemia: a case study and literature review
    TIAN Xiaofang, LIU Liping, YUAN Liying, REN Hong, WANG Zhaohui, SHI Hao
    Journal of Internal Medicine Concepts & Practice    2025, 20 (03): 191-197.   DOI: 10.16138/j.1673-6087.2025.03.02
    Abstract168)   HTML10)    PDF(pc) (3558KB)(405)       Save

    Objective To explore the diagnostic and therapeutic strategies for non-traditional immunoglobulin-related renal amyloidosis by analyzing the clinical management of a patient with heavy and light chain renal amyloidosis and biclonal paraproteinemia. Methods The clinical data of a patient diagnosed with biclonal paraproteinemia and renal amyloidosis at the Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine and long-term follow-up from 2021 to 2024 were collected and analyzed, and relevant domestic and foreign literature was reviewed. Results The main symptoms in a 72-year-old male presented with foamy urine, facial and bilateral lower limb edema. Biclonal (IgM κ and IgA, λ) gammopathy were detected, heavy and light-chain renal amyloidosis (IgA-λ) was diagnosed by renal biopsy. There was no obvious involvement in the heart. A small number of monoclonal CD38+ B cells were detected through immunophenotyping in bone marrow, while the L265P mutation of the MYD88 gene was negative in it. There was no lymph node enlargement or extranodal lesions, the underlying hematological disease was a B-lymphocyte proliferative disorder. After initial treatment with a rituximab-based regimen, the treatment was adjusted to daratumumab combined with lenalidomide which was targeting CD38. The patient quickly achieved complete hematological remission and a renal response, and complete renal remission was achieved during subsequent treatment. Literature review showed that there are only a few case reports on biclonal paraprotein associated with renal amyloidosis, and only one case of renal amyloidosis associated with heavy and light-chain. In amyloidosis caused by B cell or lymphoplasmacytic clones, rituximab-based regimens are the main treatment, but hematological and organ responses are not ideal. The daratumumab combination regimen may be effective for patients with pathogenic clones of CD38+ B cells. Conclusions There is no consensus or guideline for the diagnosis and treatment of light-chain amyloidosis with biclonal paraprotein. Accurately identifying the pathogenic clone, determining the treatment target, and formulating individualized combination drug regimens are helpful for patients to achieve more profound remission of hematology and organs.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Clinical features, diagnosis and phenotype and genotype analysis of a family with a mitochondrial DNA A3243G gene mutation
    CHEN Ruihua, DING Xiaoying, LIU Fang, WANG Qingguo, WANG Yufan
    Journal of Internal Medicine Concepts & Practice    2025, 20 (03): 204-209.   DOI: 10.16138/j.1673-6087.2025.03.04
    Abstract332)   HTML13)    PDF(pc) (2933KB)(361)       Save

    Objective To analyze the clinical and imaging characteristics of a patient with maternally inherited diabetes and deafness syndrome (MIDD) complicated with cerebral artery occlusion and explore the trend of mitochondrial gene mutations in her pedigree. Methods The study reviewed a patient with diabetes, deafness, dizziness and stroke like attack, who was diagnosed as mitochondrial encephalomyopathy with lactic acidosis and stroke-like episode (MELAS) syndrome and the medical history of her family members. Based on medical history, laboratory examinations, imaging examinations, genetic tests, and existing literature reports, the relationship between clinical characteristics of the patients in this family and pathogenic gene heterogeneity was analyzed. Results The proband presented typical clinical manifestations of MIDD, and the results of first-generation mitochondrial gene sequencing showed a chrM: 3243A>G (tRNA Leu1) mutation. Subsequently, next generation sequencing was performed using the blood of the proband and their maternal relatives, and the results showed that the blood mutation rate of proband was 42.15%, and most of the maternal relatives also exhibited different degrees of 3243A>G mutations. Conclusions The clinical manifestations of MIDD patients are complicated, and they are prone to brain atrophy and cerebrovascular occlusion. Sequencing analysis and early brain imaging evaluation is recommended to perform in diabetic patients with extreme emaciation and progressive hearing loss. Next-generation sequencing could help to clarify mutation heterogeneity. The higher heterogeneity and earlier onset age might indicate the more serious condition of the disease, which needs early prevention and diagnosis.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Construction of necroptosis-related lncRNA risk model of pancreatic cancer based on bioinformatics
    YANG Ziyun, YAO Weiyan
    Journal of Internal Medicine Concepts & Practice    2025, 20 (03): 232-241.   DOI: 10.16138/j.1673-6087.2025.03.08
    Abstract156)   HTML8)    PDF(pc) (3972KB)(347)       Save

    Objective To construct a prognostic risk model for pancreatic cancer based on necroptosis-related long non-coding RNA (NRL). Methods The gene expression data and clinical data were from the Cancer Genome Atlas (TCGA) and GTEx databases, including 171 normal pancreas and 178 pancreatic cancer samples. LASSO regression and Cox regression analysis were used to identify NRL associated with pancreatic cancer prognosis to construct the risk model. The predictive value of the model was evaluated using receiver operating characteristic (ROC) curves and validated in the Clinical Proteomic Tumor Analysis Consortium (CPTAC) database. Gene enrichment analysis, immune infiltration analysis, and chemotherapy drug sensitivity analysis were also conducted. Results The eight NRL (LINC01559, TMEM161B-AS1, AL157392.3, AC099850.3, AC136475.3, AL162274.2, MIR217HG, UNC5B-AS) were screened for constructing the NRL risk model. Survival analysis indicated that patients in the high-risk group had poorer prognosis (P<0.001). ROC curves were both >0.6, confirming the accuracy of the model. Regression analysis confirmed that the model was an independent prognostic factor for pancreatic cancer patients (P<0.05), and CPTAC data showed that the effectiveness of this model was good. Additionally, there were significant differences (P<0.05) in pathway enrichment, immune cell infiltration, tumor mutation burden, expression of immune checkpoints, and chemotherapy drug sensitivity between the high risk and low risk groups. Conclusions The risk model constructed based on 8 NRL can effectively predicts the prognosis of pancreatic cancer, and strongly correlated with the level of immune infiltration in pancreatic cancer which may provide new reference for immunotherapy and chemotherapy drug selection.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Advances in pathogenesis and treatment of chronic obstructive pulmonary disease complicated with sarcopenia
    WANG Yi, HUANG Hui
    Journal of Internal Medicine Concepts & Practice    2025, 20 (05): 415-419.   DOI: 10.16138/j.1673-6087.2025.05.13
    Abstract149)   HTML2)    PDF(pc) (468KB)(320)       Save

    Chronic obstructive pulmonary disease (COPD) is one of the most common chronic diseases of the respiratory tract, with a high mortality and disability rate. Sarcopenia is an important extrapulmonary manifestation in COPD patients, and its incidence rate is not low. The pathogenesis of COPD complicated with sarcopenia involves oxidative stress, systemic inflammatory response, autophagy, malnutrition and decreased physical activity, etc. Current research has shown that exercise intervention, nutritional support, and medication treatment can improve patients’ muscle strength and physical mobility, thereby enhancing patient prognosis. This article comprehensively reviews the pathogenesis and treatment of COPD complicated with sarcopenia, aiming to provide a valuable reference for disease research, diagnosis and treatment.

    Reference | Related Articles | Metrics | Comments0
    Clostridioides difficile toxin positivity prolongs hospital stay and increases costs for critically ill patients in emergency patients
    YU Meiling, LI Jiaoyan, LI Jian, CHEN Ying, ZHAO Bing, MAO Enqiang, YANG Zhitao
    Journal of Internal Medicine Concepts & Practice    2025, 20 (03): 216-223.   DOI: 10.16138/j.1673-6087.2025.03.06
    Abstract603)   HTML5)    PDF(pc) (1058KB)(315)       Save

    Objective To explore the influence of Clostridioides difficile (C. difficile)positivity on clinical outcomes and identify associated risk factors in intensive care unit(ICU) patients. Methods A retrospective analysis was conducted on 2 036 patients admitted to the emergency ICU of Ruijin Hospital from 2013 to 2022, comparing outcomes between C. difficile-positive (n=225) and C. difficile negative (n=1 811) groups. Multivariate regression analysis was used to identify risk and protective factors. Results Significantly prolonged hospital stays (B=18.734 d, 95% CI: 14.683-22.785) and higher treatment costs (B=68 854.912, 95% CI: 46 579.159-91 130.665) in the C. difficile-positive group, with no statistically significant difference in mortality between groups. Multivariate analysis identified carbapenem use (OR=1.58, 95% CI: 1.16-2.15), bloodstream infection (OR=1.77, 95% CI: 1.17-2.66), and biliary tract infection (OR=1.79, 95% CI: 1.03-3.10) as risk factors for C. difficile positivity. Protective factors included metronidazole use (OR=0.58, 95% CI: 0.40-0.84), cephalosporin use (OR=0.54, 95% CI: 0.39-0.74), and female sex (OR=0.60, 95% CI: 0.44-0.83). Conclusions C. difficile positivity in critically ill patients did not affect mortality but prolonged hospitalization and increased costs. Both risk and protect factors for C. difficile are identified.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Correlation study on circadian rhythm disturbance and pathological characteristics of non-alcoholic fatty liver disease
    HUANG Lei, ZHANG Chenli, YAN Hua, SHI Dongmei
    Journal of Internal Medicine Concepts & Practice    2025, 20 (03): 224-231.   DOI: 10.16138/j.1673-6087.2025.03.07
    Abstract283)   HTML7)    PDF(pc) (5683KB)(308)       Save

    Objective To investigate the key signal molecules in the regulation of biological clock and lipid metabolism of non-alcoholic fatty liver disease(NAFLD)and its effect on lipid metabolism, to provide insights for the prevention and treatment of NAFLD. Methods The animal models with NAFLD were established and classified, including circadian rhythm disorder + high-fat diet(HFC) group, circadian rhythm disorder + normal diet(NC) group, high-fat diet (HF) group and normal diet (N) group. Hematoxylin and eosin (HE) and oil red O staining were used to detect the fat deposition in the model liver tissues; enzyme-linked immunosorbent assay(ELISA) was used to detect the serum lipids in the mice; immunoblotting was performed to detect the protein expression of brain and muscle arnt-like 1(BMAL1) gene,and the correlation between BMAL1 gene and the liver pathological features was estimate. For the HFC and HF groups, mRNA bioinformatics analysis was performed to identify key circadian clock genes in NAFLD. Results Circadian rhythm disturbance increased body weight and induced obesity in mice. At week 15, the HFC group showed significantly higher weight than the HF group (t=23.18, P<0.000 1), and the NC group exceeded the N group (t=5.24, P<0.000 1). It also promoted hepatic lipid deposition: lipid content progressively increased in the HFC group (F=10.13, P<0.05) and NC group (F=8.89, P<0.05) over time. Moreover, it exacerbated dyslipidemia: TC and LDL-C levels in the HFC group were significantly higher than the HF group at ZT0, ZT8 and ZT16 (F=23.3, P<0.0001; F=68.1, P<0.000 1); similarly, the NC group had elevated TC and LDL-C versus the N group (F=3.9, P<0.000 1; F=5.8, P<0.000 1). BMAL1 expression exhibited rhythmic fluctuations, with higher protein levels at ZT16 than ZT8 in HFC and NC groups, showing a significant positive correlation with fatty liver severity (r=0.995, P=0.022). Conclusions A high-fat diet causes abnormal lipid metabolism in mice; the disturbance of circadian rhythm exacerbates the abnormal lipid metabolism in mice, increases lipid deposition in the liver, and promotes the progression of fatty liver. The biological clock gene BMAL1 is closely related to the metabolism of non-alcoholic fatty liver disease. High expression of BMAL1 may induce fat accumulating in the liver.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Intervention effect of five senses awakening nursing mode based on the circadian rhythm on the conscious state of hospitalized patients with cerebral coma
    LYU Zhuobei, ZHU Lin, RONG Lan, LYU Xiaoqiong, CHU Jiani, CHENG Zhiying
    Journal of Internal Medicine Concepts & Practice    2025, 20 (04): 306-311.   DOI: 10.16138/j.1673-6087.2025.04.08
    Abstract570)   HTML2)    PDF(pc) (883KB)(296)       Save

    Objective To explore the impact of five senses awakening nursing mode based on the circadian rhythm in conscious hospitalized patients with cerebral coma. Methods Using convenience sampling method, a total of 43 patients with cerebral coma admitted to the Department of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine from May 2023 to April 2024 were selected. The patients in the even-numbered wards were set as the observation group (n=22), and those in the odd-numbered wards were set as the control group (n=21). The control group received routine nursing mode while the observation group received five-sense awakening nursing mode in addition to routine nursing. A comparison was made between the two groups at different periods regarding Glasgow coma score (GCS), coma recovery scale-revised (CRS-R), recovery efficiency and recovery time. Results There was an interaction between the group factor and the time factor in the GCS score and the CRS-R score in the two groups (F=9.765, P<0.001; F=12.846, P<0.001). After the intervention, there were significant differences in the changes of the GCS and the CRS-R score at different time points between the two groups (F=243.934, P<0.001; F=239.111, P<0.001). There were statistical differences in the changes of the GCS and the CRS-R score between the two groups (F=5.040, P<0.05;F=7.779, P<0.05).The recovery rate of the observation group was higher than that of the control group (P<0.05), and the recovery time was shorter than that of the control group (P<0.01). Conclusions The five- sensory stimulation nursing approach based on the circadian rhythm, can improve the consciousness state of patients with cerebral coma and facilitate their awakening.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Prognostic factor analysis of sarcopenia in elderly patients with heart failure and preserved ejection fraction
    YANG Qirui, BAI Tingting, JIANG Qianwen, ZHANG Weiqi, LU Yiyin, ZHAO Wei, WU Fang, LI Feika
    Journal of Internal Medicine Concepts & Practice    2025, 20 (03): 210-215.   DOI: 10.16138/j.1673-6087.2025.03.05
    Abstract332)   HTML9)    PDF(pc) (1013KB)(286)       Save

    Objective To explore the prognosis and related risk factors of sarcopenia in elderly patients with heart failure and preserved ejection fraction (HFpEF) in some areas of Shanghai. Methods A total of 261 elderly patients (age ≥60 years) with HFpEF were consecutively enrolled from January 2018 to June 2020 at Ruijin Hospital,Shanghai Jiao Tong University School of Medicine and collaborating community health service centers/nursing homes. The subjects were grouped according to the presence of sarcopenia, and the relevant clinical data were collected. The follow-up endpoint was subject’s readmission for heart failure and (or) all-cause death, and the deadline of follow-up was December 2022. The Kaplan-Meier survival analysis curve and Log-Rank test were performed to compare the outcome between the two groups, and univariate and multivariate Cox proportional hazards regression models were applied to analyze the relevant risk factors of adverse outcome. Results The average time of follow-up was (38.6±11.5) months in the two groups, was (37.4±13.0) months in the sarcopenia group and (39.1±9.3) months in the control group, respectively. The results of Kaplan-Meier survival analysis curve showed that the sarcopenia group had significantly worse prognosis than that in the control group (P<0.05), and multivariate Cox regression analysis showed that sarcopenia was an independent risk factor for poor prognosis in elderly patients with HFpEF (P<0.05). Conclusions This study indicates that sarcopenia was an independent predictor of adverse prognosis in elderly patients with HFpEF. These findings highlight the clinical importance of early identification and management of sarcopenia in these patients, which may help improve clinical outcomes.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Clinical evaluation of the modified open wound sutureless labial gland biopsy technique for patient with Sjögren syndrome
    CHEN Yabing, GAO Jie, XU Xia, ZHAO Dongbao
    Journal of Internal Medicine Concepts & Practice    2025, 20 (04): 312-315.   DOI: 10.16138/j.1673-6087.2025.04.09
    Abstract261)   HTML5)    PDF(pc) (855KB)(284)       Save

    Objective To explore the clinical value of modified open-wound sutureless labial gland biopsy for patients with Sjögren syndrome. Methods A total of 24 patients who underwent labial gland biopsy in our department from March 2023 to April 2025 were divided into the sutureless labial gland biopsy (SLSGB) group and the traditional labial salivary gland biopsy (TLSGB) group. The numerical rating scale (NRS) 0-10 was used to evaluate the postoperative recovery time and incision pain at 2 h, 1 d, and 7 d after surgery in both groups. Results The postoperative recovery time score was (6.67±0.82) points in the TLSGB group and (2.00±0.00) points in the SLSGB group (P< 0.001). The NRS scores at 2 h, 1 d, and 7 d after surgery were (5.83±0.98), (2.67±0.52), and (2.00±0.63) points in the TLSGB group, and (1.72±0.46), 0, and 0 points in the SLSGB group, respectively. There were significant differences between the two groups at 2 h and 1 d after surgery (both P<0.05), but there was no statistical difference at 7 d after surgery (P>0.05). Conclusions Open incision labial gland biopsy is less invasive, less prone to secondary injury, does not require suture removal, is easy to operate, and rarely causes complications. It can reduce significantly the economic and time costs and it’s more easily accepted by patients.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Advances in stem cell therapy for scleroderma
    LIN Ruilian, MA Lili, CHEN Jia
    Journal of Internal Medicine Concepts & Practice    2025, 20 (04): 340-344.   DOI: 10.16138/j.1673-6087.2025.04.15
    Abstract209)   HTML0)    PDF(pc) (940KB)(282)       Save

    Scleroderma is an autoimmune connective tissue disorder characterized by fibrosis of the skin and internal organs. Currently, there is no fully satisfactory treatment for this condition. In recent years, stem cells have emerged as a promising therapeutic strategy for a variety of diseases, owing to their capacities for self-renewal and multilineage differentiation. Substantial advances have been achieved in applying stem cell therapy to scleroderma. This review summarizes the mechanisms and clinical progress of stem cell-based treatments for scleroderma, with the aim of providing new insights for basic research and supporting evidence for future clinical applications.

    Reference | Related Articles | Metrics | Comments0
    Discussion on effect and mechanism of hypoglycemic drugs on Parkinson disease
    ZHANG Haihan, JING Wei, SHAN Yuetong, ZHANG Yuling, CHEN Anan, LONG Siqi, WANG Yuze, LI Wei, PAN Weidong
    Journal of Internal Medicine Concepts & Practice    2025, 20 (05): 399-404.   DOI: 10.16138/j.1673-6087.2025.05.10
    Abstract179)   HTML2)    PDF(pc) (486KB)(279)       Save

    Parkinson disease (PD) is a chronic neurodegenerative disease, and the pathgenesis is mainly related to neuronal degeneration and abnormal accumulation of αSyn. Some studies have shown that patients with PD are more likely to suffer from type 2 diabetes mellitus. Hypoglycemic drugs regulate blood glucose through modulating glucose metabolism and improving insulin sensitivity. Some of hypoglycemic drugs also have neuroprotective or antioxidant effect, and their mechanisms of action in neurodegenerative diseases have been extensively studied in recent years. This article reviews the pathological basis and related pathogenesis of PD, exploring the effect of hypoglycemic drugs on the progression of PD.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Research progress on oxaliplatin-induced peripheral neuropathy
    ZHANG Yi, QIU Xiaoxia
    Journal of Internal Medicine Concepts & Practice    2025, 20 (05): 393-398.   DOI: 10.16138/j.1673-6087.2025.05.09
    Abstract130)   HTML6)    PDF(pc) (502KB)(258)       Save

    Oxaliplatin-induced peripheral neuropathy (OIPN) is a common dose-limiting toxic reaction in chemotherapy for gastrointestinal malignancies such as colorectal and gastric cancers, is characterized by sensory abnormalities and pain that substantially impair treatment efficacy and quality of life. This article provides a systematic review of the pathogenesis, diagnostic criteria, contributing factors, and therapeutic strategies of OIPN, aiming to raise clinician’s attention to OIPN and provide a reference for future clinical management in oncological practice.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Advances in understanding the association between hyperuricemia and cardiovascular diseases
    JIN Zhengyi, LIU Qilong, HU Jiaqi, XU Xia, GAO Jie
    Journal of Internal Medicine Concepts & Practice    2025, 20 (04): 334-339.   DOI: 10.16138/j.1673-6087.2025.04.14
    Abstract171)   HTML8)    PDF(pc) (983KB)(249)       Save

    Hyperuricemia is a disease caused by abnormal purine metabolism. The prevalence of hyperuricemia is increasing annually in China. Elevated uric acid levels not only lead to gout attacks but are also associated with the occurrence and development of cardiovascular diseases. Research indicates that hyperuricemia can facilitate the onset and progression of cardiovascular diseases through promoting inflammation, causing endothelial dysfunction, and over activating the renin-angiotensin-aldosterone system. This review discusses the association between hyperuricemia and various cardiovascular diseases, including coronary atherosclerosis, atrial fibrillation, hypertension, and heart failure.

    Reference | Related Articles | Metrics | Comments0
    Application of cloud visitation in the transformation of emergency integrated nursing mode
    JU Wang, CHEN Yu, YU Jie
    Journal of Internal Medicine Concepts & Practice    2025, 20 (03): 254-258.   DOI: 10.16138/j.1673-6087.2025.03.11
    Abstract437)   HTML2)    PDF(pc) (954KB)(243)       Save

    Objective To explore the effect of cloud visitation in patients receiving emergency integrated nursing mode. Methods Patients in our hospital from January 1, 2023 to June 30, 2023 were selected as the study objects. A total of 120 patients admitted from January 1, 2023 to March 31, 2023 were enrolled as the observation group, adopting the cloud visitation method. 120 patients admitted from April 1, 2023 to June 30, 2023 were enrolled as the control group, adopting the traditional visitation method. The anxiety degree, medication compliance and nursing satisfaction degree of the two groups were compared during the study period. Results The anxiety score of the observation group was 59 (57,63) points, was significantly lower than that in the control group [69 (67,71) points (P<0.01)], the medication compliance of observation group was significantly higher than that in the control group (P<0.01), and the satisfaction degree of nursing work of the observation group was significantly higher than that in the control group (P<0.01). Conclusions The implementation of cloud visitation mode in the integrated nursing management mode for emergency patients is conducive to optimizing visitation management, improving patients’ anxiety, ameliorating patients’ medication compliance, and enhancing their satisfaction with nursing work.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Secuchiumab in treatment of plaque psoriasis complicated with renal insufficiency: a case analysis
    ZHOU Ting, XIE Peitao, ZHANG Liang
    Journal of Internal Medicine Concepts & Practice    2025, 20 (03): 259-261.   DOI: 10.16138/j.1673-6087.2025.03.12
    Abstract247)   HTML11)    PDF(pc) (5900KB)(234)       Save

    The 45-year-old male patient had uremia due to gout and hypertension in the past and underwent kidney transplantation, currently complicated with renal insufficiency. To prevent rejection, the patient administrated mycopherol sodium enteric-covered tablets 540 mg,twice a day, tacrolimus 1 mg in the morning and 2 mg in the evening and methylprednisolone 4 mg orally for long-term. Nifedipine controlled release tablets (30 mg, twice a day) were used for hypertension. Following a diagnosis of depression 3 years ago, medication was commenced with trazodone (50 mg, twice a day) and quetiapine fumarate (200 mg, twice a day) orally. The patient got novel coronavirus infection and was cured in December 2022. The plaque psoriasis was diagnosed in January 2023, and the treatment effect of oral anti-allergy drugs and topical hormone symptomatic treatment was not good for him. After being admitted to the hospital and receiving treatment of secukinumab 300 mg, psoriasis area and severity index (PASI) score and dermatology life quality index(DLQI) score of the patient were significantly improved, and he also showed well tolerated. The treatment of the case provides reference for the similar patients with psoriasis complicated with renal insufficiency.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Effects of prior COVID-19 infection on autologous hematopoietic stem cell transplantation in multiple myeloma patients
    JIN Shiwei, PAN Mengmeng, XU Jie, GAO Shan, WANG Yan, LIU Yuanfang, TAO Yi, ZHANG Weiping, MI Jianqing
    Journal of Internal Medicine Concepts & Practice    2025, 20 (04): 289-295.   DOI: 10.16138/j.1673-6087.2025.04.05
    Abstract98)   HTML3)    PDF(pc) (1016KB)(227)       Save

    Objective To assess the impact of prior COVID-19 infection on clinical outcomes in terms of engraftment, treatment emergent complications, and immune reconstitution in multiple myeloma (MM) patients after autologous hematopoietic stem cell transplantation (auto-HSCT). Methods Data of MM patients who underwent auto-HSCT from July 1, 2022, to July 31, 2023, in Ruijin Hospital, Shanghai Jiao Tong University School of Medicine were retrospectively analyzed. The clinical indices including engraftment time, transplant-related infection, engraftment syndrome, immunoglobulin reconstitution, circulating lymphocytes composition, and short-term efficacy were compared in the two cohorts who had or had not been infected by COVID-19 prior to auto-HSCT. Results Sixty-three patients were included. Thirty-two recovered from COVID-19 before auto-HSCT and the remaining 31 did not show evidence of COVID-19 infection. No differences were observed across the two groups in the rates of infections, neutrophil engraftment, platelet engraftment, as well as the incidence of engraftment syndrome. Preceding auto-HSCT, the numbers of CD3+T, CD3+CD8+T and CD19+B lymphocytes in patients recovered from COVID-19 were significantly higher than those in COVID-19-free group (P<0.05); however, such a disparity was not present after auto-HSCT. At day 8 post-infusion, interferon(IFN)-γ level of COVID-19 group was higher as compared with that of non-infected group (P=0.011).The rate of polyclonal immunoglobulins recovery in COVID-19-affected cohort was 3.1%, which was lower than that in non-infected patients three months post auto-HSCT (P=0.026), while there was no difference in depth of therapeutic response between the two groups. Conclusions The data indicates that auto-HSCT can be safely administered in MM patients who completely recovered from COVID-19, but their immunoglobulins reconstitution was relatively delayed upon adoptive transfer. Timely and routine intravenous immunoglobin supplements are recommended for minimizing the risk of infection.

    Table and Figures | Reference | Related Articles | Metrics | Comments0